vs
NEPHROS INC（NEPH）与Rithm Property Trust Inc.（RPT）财务数据对比。点击上方公司名可切换其他公司
NEPHROS INC的季度营收约是Rithm Property Trust Inc.的1.4倍（$4.7M vs $3.4M），Rithm Property Trust Inc.净利率更高（95.4% vs 1.3%，领先94.1%），NEPHROS INC同比增速更快（22.2% vs -39.7%），过去两年NEPHROS INC的营收复合增速更高（15.9% vs -43.2%）
Nephros Inc是一家医疗科技企业，主要研发和销售高性能净水系统、感染防控产品及肾脏护理解决方案，产品主要供给北美地区的医院、透析诊所以及长期护理机构，用于降低水传播病原体风险，提升患者诊疗效果。
Rithm Property Trust Inc.旗下的里思资本是一家总部位于纽约的美国投资管理公司，核心业务聚焦于房地产投资及另类投资领域，是该赛道颇具影响力的专业投资机构。
NEPH vs RPT — 直观对比
营收规模更大
NEPH
是对方的1.4倍
$3.4M
营收增速更快
NEPH
高出61.9%
-39.7%
净利率更高
RPT
高出94.1%
1.3%
两年增速更快
NEPH
近两年复合增速
-43.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.7M | $3.4M |
| 净利润 | $62.0K | $3.2M |
| 毛利率 | 58.4% | — |
| 营业利润率 | 0.4% | 99.6% |
| 净利率 | 1.3% | 95.4% |
| 营收同比 | 22.2% | -39.7% |
| 净利润同比 | -82.2% | 11.2% |
| 每股收益（稀释后） | $0.01 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEPHRPT
| Q4 25 | $4.7M | $3.4M | ||
| Q3 25 | $4.8M | $4.0M | ||
| Q2 25 | $4.4M | $4.2M | ||
| Q1 25 | $4.9M | $249.0K | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $3.5M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $3.5M | — |
净利润NEPHRPT
| Q4 25 | $62.0K | $3.2M | ||
| Q3 25 | $337.0K | $-273.0K | ||
| Q2 25 | $237.0K | $1.9M | ||
| Q1 25 | $558.0K | $-3.4M | ||
| Q4 24 | $349.0K | — | ||
| Q3 24 | $183.0K | — | ||
| Q2 24 | $-289.0K | — | ||
| Q1 24 | $-169.0K | — |
毛利率NEPHRPT
| Q4 25 | 58.4% | — | ||
| Q3 25 | 61.2% | — | ||
| Q2 25 | 63.2% | — | ||
| Q1 25 | 64.7% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 58.8% | — | ||
| Q1 24 | 62.1% | — |
营业利润率NEPHRPT
| Q4 25 | 0.4% | 99.6% | ||
| Q3 25 | 6.6% | -6.2% | ||
| Q2 25 | 5.6% | 45.7% | ||
| Q1 25 | 11.6% | -1416.5% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | -9.7% | — | ||
| Q1 24 | -5.7% | — |
净利率NEPHRPT
| Q4 25 | 1.3% | 95.4% | ||
| Q3 25 | 7.1% | -6.8% | ||
| Q2 25 | 5.4% | 45.1% | ||
| Q1 25 | 11.4% | -1363.1% | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | -8.9% | — | ||
| Q1 24 | -4.8% | — |
每股收益（稀释后）NEPHRPT
| Q4 25 | $0.01 | $-0.26 | ||
| Q3 25 | $0.03 | $-0.03 | ||
| Q2 25 | $0.02 | $0.01 | ||
| Q1 25 | $0.05 | $-0.08 | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.4M | $79.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.2M | $291.6M |
| 总资产 | $13.6M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEPHRPT
| Q4 25 | $5.4M | $79.3M | ||
| Q3 25 | $5.2M | $81.4M | ||
| Q2 25 | $5.1M | $98.6M | ||
| Q1 25 | $4.1M | $97.4M | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $3.6M | — |
股东权益NEPHRPT
| Q4 25 | $10.2M | $291.6M | ||
| Q3 25 | $10.0M | $291.7M | ||
| Q2 25 | $9.6M | $294.7M | ||
| Q1 25 | $9.3M | $296.1M | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $7.9M | — | ||
| Q1 24 | $8.2M | — |
总资产NEPHRPT
| Q4 25 | $13.6M | $1.0B | ||
| Q3 25 | $13.2M | $1.0B | ||
| Q2 25 | $12.2M | $1.0B | ||
| Q1 25 | $11.8M | $1.0B | ||
| Q4 24 | $11.2M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $11.1M | — | ||
| Q1 24 | $11.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.0K | $-8.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.71× | -2.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NEPHRPT
| Q4 25 | $230.0K | $-8.3M | ||
| Q3 25 | $99.0K | $-5.8M | ||
| Q2 25 | $994.0K | $-25.0K | ||
| Q1 25 | $322.0K | $-1.6M | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $-623.0K | — | ||
| Q2 24 | $-501.0K | — | ||
| Q1 24 | $-672.0K | — |
资本支出强度NEPHRPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率NEPHRPT
| Q4 25 | 3.71× | -2.56× | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 4.19× | -0.01× | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 3.74× | — | ||
| Q3 24 | -3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEPH
| Products | $4.6M | 98% |
| Other | $108.0K | 2% |
RPT
暂无分部数据
